Edwards Set To Launch “Two-Trials-In-One” For Sapien Percutaneous Valve
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will soon begin a 600-patient U.S. pivotal clinical trial for its Sapien transcatheter aortic replacement heart valve at Columbia University Medical Center and the Cleveland Clinic, the company says